Reference
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:https://doi.org/10.3322/caac.21660.
- Rex DK. Colorectal cancer screening. Gastrointest Endosc Clin N Am. 2020;30(3):xv–xvi. doi:https://doi.org/10.1016/j.giec.2020.04.001.
- Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020;17(7):414–429. doi:https://doi.org/10.1038/s41575-020-0275-y.
- Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–899. doi:https://doi.org/10.1001/archsurg.133.8.894.
- Yu L, Xu T, Zhang L, Zhu Y, Fang H, Zhang H. Tumor deposits should not be ignored in the AJCC TNM staging system for ypN(+) stage rectal cancer with neoadjuvant chemoradiotherapy. J Gastrointest Surg. 2020;24(10):2298–2301. doi:https://doi.org/10.1007/s11605-020-04675-7.
- Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007;25(11):1316–1322. doi:https://doi.org/10.1200/jco.2006.06.1218.
- Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schröder FH. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol. 2007;177(1):107–112; discussion 12. doi:https://doi.org/10.1016/j.juro.2006.08.068.
- Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:https://doi.org/10.1200/JCO.2007.12.9791.
- Yang Z, Bai Y, Liu M, Hu X, Han P. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer: a population-based study. Cancer Med. 2020;9(24):9303–9314. doi:https://doi.org/10.1002/cam4.3535.
- Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103(2):402–408. doi:https://doi.org/10.1002/cncr.20778.
- Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg. 2018;153(6):588–589. doi:https://doi.org/10.1001/jamasurg.2018.0501.
- Longato E, Vettoretti M, Di Camillo B. A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models. J Biomed Inform. 2020;108:103496. doi:https://doi.org/10.1016/j.jbi.2020.103496.
- Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi:https://doi.org/10.1016/j.eururo.2018.08.038.
- Pencina MJ, Steyerberg EW, D’Agostino RB. Sr. Net reclassification index at event rate: properties and relationships. Stat Med. 2017;36(28):4455–4467. doi:https://doi.org/10.1002/sim.7041.
- Yu C, Zhang Y. Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis. BMC Gastroenterol. 2020;20(1):347. doi:https://doi.org/10.1186/s12876-020-01464-z.
- Kang BH, Song C, Kang SB, Lee KW, Lee HS, Kim JS. Nomogram for predicting the pathological tumor response from pre-treatment clinical characteristics in rectal cancer. Anticancer Res. 2020;40(4):2171–2177. doi:https://doi.org/10.21873/anticanres.14177.
- Naffouje S, Sabesan A, Powers BD, et al. Patient risk subgroups predict benefit of adjuvant chemotherapy in stage II rectal cancer patients following neoadjuvant chemoradiation and total mesorectal excision. Clin Colorectal Cancer. 2021. doi:https://doi.org/10.1016/j.clcc.2021.02.006.
- São Julião GP, Habr-Gama A, Vailati BB, Araujo SEA, Fernandez LM, Perez RO. New strategies in rectal cancer. Surg Clin North Am. 2017;97(3):587–604. doi:https://doi.org/10.1016/j.suc.2017.01.008.
- Bahadoer RR, Dijkstra EA, van Etten B, RAPIDO Orative Investigators, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42. doi:https://doi.org/10.1016/S1470-2045(20)30555-6.
- Al-Abed Y, Parker M, Arulampalam T, Tutton M. Survival following rectal cancer surgery: does the age matter? Acta Chir Belg. 2019;119(5):282–288. doi:https://doi.org/10.1080/00015458.2018.1515395.
- Chan SY, Suwanabol PA, Damle RN, et al. Characterizing short-term outcomes following surgery for rectal cancer: the role of race and insurance status. J Gastrointest Surg. 2016;20(11):1891–1898. doi:https://doi.org/10.1007/s11605-016-3241-9.
- Wang X, Cao W, Zheng C, Hu W, Liu C. Marital status and survival in patients with rectal cancer: an analysis of the Surveillance, Epidemiology and End Results (SEER) database. Cancer Epidemiol. 2018;54:119–124. doi:https://doi.org/10.1016/j.canep.2018.04.007.
- Glynne-Jones R, Wyrwicz L, Tiret E, ESMO Guidelines Committee, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–iv40. doi:https://doi.org/10.1093/annonc/mdx224.
- Jin M, Frankel WL. Lymph node metastasis in colorectal cancer. Surg Oncol Clin N Am. 2018;27(2):401–412. doi:https://doi.org/10.1016/j.soc.2017.11.011.
- Feeney G, Sehgal R, Sheehan M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25(33):4850–4869. doi:https://doi.org/10.3748/wjg.v25.i33.4850.
- Breugom AJ, Swets M, Bosset JF, et al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol. 2015;16(2):200–207. doi:https://doi.org/10.1016/S1470-2045(14)71199-4.
- Xie Y, Huang Y, Ruan Q, et al. Impact of tumor site on lymph node status and survival in colon cancer. J Cancer. 2019;10(11):2376–2383. doi:https://doi.org/10.7150/jca.32038.
- Li X, Lu H, Xu K, Wang H, Liang X, Hu Z. Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy. BMC Cancer. 2017;17(1):227. doi:https://doi.org/10.1186/s12885-017-3222-8.